Table 1.
Details of primers used in the present study.
Fig 1.
Design of tetra primers for ARMS-PCR to target the rs1617640 C > T/G polymorphism.
(a) The target locus as visualized in the NCBI-dbSNP database. (b) The rs1617640polymorphism is depicted at single nucleotide resolution. (c) The sequence of the targeted region, including the SNP and flanking sequences (approximately 400-600 bp upstream and downstream), was downloaded for primer designing. (d) The designed primers are displayed at single nucleotide resolution.
Table 2.
Comparative analyses of the clinical parameters between diabetic retinopathy (DR) cases and control group (CDR).
Fig 2.
Distribution of genotypes and alleles among the case and control samples during the present study.
(a) Overall distribution of all genotypes. (b) Overall distribution of all alleles. (c) Distribution of normal genotype CC across the groups. (d) Distribution of homozygous mutant genotype GG. (e) Distribution of homozygous mutant genotype TT. (f) Distribution of heterozygous mutant genotype CT. (g) Distribution of heterozygous mutant genotype CG. (h) Distribution of double mutant genotype TG. (i) Distribution of trisomy genotype CTG. (j) Distribution of normal allele C across the groups. (k) Distribution of mutant allele G. (l) Distribution of mutant allele T.
Table 3.
Genotype and allele frequencies for EPO polymorphism (rs1617640C>T/G) across the samples and their association with diabetic retinopathy during present study.